Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Br J Haematol. 2018 Mar 12;181(1):111–121. doi: 10.1111/bjh.15157

Figure 1. Atorvastatin treatment improves renal function in Sickle Cell mice.

Figure 1

Sickle cell mice were treated with 10 mg/kg/day Atorvastatin for 8 weeks. Significant improvement in maximal urinary concentrating ability (water-deprived) and glomerular filtration rate (GFR) was demonstrated at 4 and 8 weeks (a) and (b), n =8. **p<0.01 and ***p<0.001